Cabozantinib Impurity 33 | CAS 190728-27-9 - Request Quote
Cabozantinib Impurity 33
| SZ CAT No: | SZ-C112049 |
| CAS No | 190728-27-9 |
| Mol.F. | C17H16N2O3 |
| Mol.Wt. | 296.3 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cabozantinib Impurity 33 is chemically 2-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline. Cabozantinib Impurity 33 is supplied with detailed characterization data compliant with regulatory guideline. Cabozantinib Impurity 33 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabozantinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 190728-27-9
Purchase 190728-27-9
Order 190728-27-9
Enquire 190728-27-9
price of 190728-27-9
190728-27-9 Supplier
190728-27-9 Manufacturer
190728-27-9 Exporter
buy high quality Cabozantinib Impurity 33
Purchase Cabozantinib Impurity 33
Cabozantinib Impurity 33 suppliers
Cabozantinib Impurity 33 manufacturers
Cabozantinib Impurity 33 price
Order Cabozantinib Impurity 33
Enquire Cabozantinib Impurity 33
Cabozantinib Impurity 33 cost
Cabozantinib Impurity 33 Supplier
Cabozantinib Impurity 33 Distributor
Cabozantinib Impurity 33 for Method Validation
Cabozantinib Reference Standard
Cabozantinib Impurity 33 for ANDA Filing
Cabozantinib Impurity 33 for Forced Degradation Studies
Cabozantinib Impurity 33 Identification Standards
Cabozantinib Impurity 33 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.